Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid alone versus hyaluronic acid plus triamcinolone for knee osteoarthritis
IRCT20210415050983N11Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in knee osteoarthritis (OA) comparing Hyaluronic acid alone with Hyaluronic acid plus triamcinolone (2 arms). Primary endpoints: Pain intensity and Physical dysfunction. Started Jul 2025; status: completed.
02
Drugs
triamcinolonehyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20210415050983N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050983N11.